Skip to main content
Podcasts

Lead Extraction After TTVR: Can We Remove It Safely?

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of EP Lab Digest or HMP Global, their employees, and affiliates. 

Interview by Isabel Vega 

Transcatheter tricuspid valve replacement (TTVR) raises important questions about managing existing pacemaker and defibrillator leads, including whether to extract them before valve implantation and how to address complications involving jailed leads. In this episode of The EP Edit, Suneet Mittal, MD, FACC, FHRS, chair of cardiology and director of electrophysiology at The Valley Hospital in Paramus, New Jersey, discusses the challenges of lead extraction after TTVR, the importance of collaboration between electrophysiology and structural heart teams, and the unanswered questions shaping patient care.

Clinical Summary

  • Tricuspid regurgitation: Approximately 25% of patients in many studies have existing pacemaker or defibrillator leads, requiring consideration of extraction before TTVR versus lead jailing.
  • Before TTVR: Electrophysiology and structural heart teams should evaluate lead management together and establish a plan for lead failure or infection, understood by clinicians and the patient.
  • After TTVR: Jailed-lead extraction feasibility remains unpredictable. Unanswered questions include lead failure frequency, extraction risks, valve damage, and management of pacemaker dependence or defibrillator therapies; follow-up beyond 30 days is needed.

Reviewed by Isabel Vega, Associate Digital Editor, Cardiovascular

Transcripts

What makes lead extraction after TTVR a particularly challenging clinical issue?
Dr Mittal:
There has been tremendous interest in managing tricuspid insufficiency in recent years. We are learning that even mild degrees of tricuspid insufficiency can increase mortality and affect quality of life.

Many patients with tricuspid regurgitation have an existing pacemaker or defibrillator. In many studies, approximately 25% of patients have a lead in place. As the field has evolved, treatment options have expanded to include full TTVR.

We are wrestling with what to do with those leads. Do we remove them before valve implantation, or do we jail them and manage the consequences afterward? There are advantages and disadvantages to both approaches, and the scientific community is trying to find a middle ground.

When evaluating a patient with existing pacemaker or defibrillator leads for TTVR, what should the team consider before proceeding?
Dr Mittal: 
First, electrophysiologists and structural cardiologists need to participate in a heart team discussion. When we look at the 2026 Heart Rhythm Society lead management guidelines, we should be asking why we are not extracting leads before the procedure. That would certainly make for a cleaner procedure, although it will not always be possible.

At a minimum, the heart team must answer this question: What is our plan if the lead fails or becomes infected? All clinicians involved, as well as the patient, need to understand that plan should a complication occur.

If extraction becomes necessary after TTVR, what factors guide your assessment of feasibility and risk?
Dr Mittal: 
If extraction is needed after TTVR, that almost always implies that the lead has been jailed. We have very little information about the feasibility of extracting jailed leads. There are case reports of successful extraction, predominantly involving pacemaker leads, but there are also reports in which the lead could not be extracted, often with harmful consequences for patients.

At present, we cannot reliably predict whether a jailed lead can be easily extracted.

How should electrophysiologists, extraction specialists, and structural heart teams collaborate on these cases?
Dr Mittal: 
Collaboration between lead extraction specialists and structural heart cardiologists is essential. One of the biggest challenges is that both areas of expertise are not always available at the same center. A center may have excellent lead extraction capabilities but may not perform advanced transcatheter valve replacement. Conversely, a center may have excellent transcatheter valve replacement capabilities but lack experienced lead extraction specialists.

That mismatch has created uncertainty about when lead extraction is appropriate and safe. We need to overcome this issue so that medical decisions are based on evidence and the best interests of the individual patient.

What are the biggest unanswered questions, and what is your main takeaway for clinicians managing these patients?
Dr Mittal: 
We need to understand how often jailed leads fail and how likely that failure is to be abrupt and harmful to the patient. We also need to understand the actual risks of lead extraction in these patients, who are often older and more frail.

Another question is how often lead extraction damages the tricuspid valve to the point that a patient is no longer a candidate for TTVR. We also do not know how best to manage patients with previously implanted defibrillators, particularly those implanted for secondary prevention of sudden cardiac death. Pacemaker dependence and implantable cardioverter-defibrillator therapies remain challenging considerations in individual patient management.

Is there anything else you would like to share with our readers?
Dr Mittal: 
This is a rapidly evolving area. One of the most positive developments over the past 1 to 2 years has been the collaborative discussions between electrophysiologists and structural heart cardiologists.

At our center, no patient with an implantable device undergoes TTVR without an electrophysiology consultation beforehand so that we can establish a plan of action.

I am hopeful that registries and other industry-sponsored studies will continue collecting data beyond the first 30 days, including at 6 months, 12 months, and longer. That follow-up will help us understand how these devices affect leads over time.

The transcript has been edited for clarity and length.